Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
670 Development of a robust manufacturing process for AB-1015, an integrated circuit T cell (ICT) products, using targeted, CRISPR integration of transgenes by electroporation (CITE) editing
Compose a Response to This Article
Other responses
No responses have been published for this article.
